Mankind Pharma Limited (MANKIND.BO) Stock Price, News & Chart

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close2,251.90

Open2,248.05

Day range2,243.152,281.00

52-week range1,909.902,640.30

Off day high0.00%

Off 52-week high−13.61%

Volume10.15K

Avg. volume (3M)48.08K

Market cap942.16B

EPS (TTM)49.42

Forward P/E32.21

P/E ratio (TTM)46.16

Dividend yield—

Beta (5Y)—

Shares outstanding413.05M

Short interest—

Earnings dateJul 30, 2026

Analyst target—

Profit margin—

Against its peers

Compare in full ›

	MANKIND.BO	ZYDUSLIFE.BO	SUNPHARMA.BO	AUROPHARMA.NS	GRANULES.BO	009420.KS
Market cap	942.16B	1.11T	4.19T	908.41B	195.74B	2.11T
P/E (TTM)	46.2	24.9	38.4	24.7	35.9	—
Forward P/E	32.2	22.7	30.9	16.9	26.9	—
Price/book	5.8	4.1	5.4	2.4	4.9	—
Dividend yield	—	0.09%	0.97%	—	0.26%	—
1-year change	−8.06%	+10.44%	−2.21%	+47.52%	+0.63%	+20.43%
Today	+1.29%	+0.39%	0.00%	−2.63%	−2.31%	−0.36%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.

Related companies

Compare ›

The businesses closest to Mankind Pharma's by what they do, from their descriptions, with the same industry weighted in.

Company	Mkt cap	Price	Today
Zydus Lifesciences LimitedZYDUSLIFE.BO · Drug Manufacturers - Specialty & Generic	1.11T	1,117.30	+0.39%
Sun Pharmaceutical Industries LimitedSUNPHARMA.BO · Drug Manufacturers - Specialty & Generic	4.19T	1,745.00	0.00%
Aurobindo Pharma LimitedAUROPHARMA.NS · Drug Manufacturers - Specialty & Generic	908.41B	1,578.80	−2.63%
Granules India LimitedGRANULES.BO · Drug Manufacturers - Specialty & Generic	195.74B	806.60	−2.31%
Hanall Biopharma Co., Ltd.009420.KS · Drug Manufacturers - Specialty & Generic	2.11T	41,400.00	−0.36%
Alkem Laboratories LimitedALKEM.NS · Drug Manufacturers - Specialty & Generic	599.62B	5,015.00	+0.22%
Lotus Pharmaceutical Co., Ltd.1795.TW · Drug Manufacturers - Specialty & Generic	46.89B	176.00	+0.57%
Piramal Pharma LimitedPPLPHARMA.BO · Drug Manufacturers - Specialty & Generic	260.76B	—	—

Other companies in Drug Manufacturers - Specialty & Generic, closest in size first.

Company	Mkt cap	Price	Today
Aurobindo Pharma LimitedAUROPHARMA.NS · Hyderabad, India	908.41B	1,578.80	−2.63%
Lupin LimitedLUPIN.BO · Mumbai, India	894.29B	1,957.00	+0.17%
Sumitomo Pharma Co., Ltd.4506.T · Osaka, Japan	875.21B	1,951.00	+3.45%
Dr. Reddy's Laboratories LimitedDRREDDY.BO · Hyderabad, India	1.03T	1,242.00	+0.82%
Cipla LimitedCIPLA.BO · Mumbai, India	1.07T	—	—
Laurus Labs LimitedLAURUSLABS.NS · Hyderabad, India	1.10T	2,012.50	−2.73%
Zydus Lifesciences LimitedZYDUSLIFE.BO · Ahmedabad, India	1.11T	1,117.30	+0.39%
Daewoong Pharmaceutical Co., Ltd069620.KS · Seoul, South Korea	1.21T	105,400.00	+0.48%

Healthcare companies of a similar market value (930.14B).

Company	Mkt cap	Price	Today
Aurobindo Pharma LimitedAUROPHARMA.NS · Drug Manufacturers - Specialty & Generic	908.41B	1,578.80	−2.63%
Abbott LaboratoriesABTT34.SA · Medical Devices	915.10B	—	—
Lupin LimitedLUPIN.BO · Drug Manufacturers - Specialty & Generic	894.29B	1,957.00	+0.17%
Bayer AktiengesellschaftBAYNN.MX · Drug Manufacturers - General	982.42B	1,000.00	0.00%
SEERS Co., Ltd.458870.KQ · Medical Devices	871.57B	—	—
Pfizer Inc.PFIZ34.SA · Drug Manufacturers - General	860.42B	37.58	−0.42%
Asahi Intecc Co., Ltd.7747.T · Medical Instruments & Supplies	1.01T	—	—
JOHNSON & JOHNSON CDR (CAD HEDGJNJ.NE · Drug Manufacturers - General	856.62B	33.00	+1.98%

Also based in New Delhi, India, then elsewhere in India.

Company	Mkt cap	Price	Today
Maruti Suzuki India LimitedMARUTI.BO · New Delhi, India	3.61T	11,482.50	+0.00%
NTPC LimitedNTPC.BO · New Delhi, India	2.94T	302.85	−1.99%
Oil and Natural Gas Corporation LimitedONGC.NS · New Delhi, India	2.83T	225.25	+0.11%
Indian Oil Corporation LimitedIOC.BO · New Delhi, India	1.84T	129.35	−0.50%
Bharat Heavy Electricals LimitedBHEL.BO · New Delhi, India	1.49T	—	—
Punjab National BankPNB.NS · New Delhi, India	1.40T	121.90	+4.82%
GAIL (India) LimitedGAIL.NS · New Delhi, India	1.10T	—	—
Power Finance Corporation LimitedPFC.NS · New Delhi, India	1.10T	—	—

Companies that serve the same markets: healthcare, life sciences, consumers, real estate, agriculture, travel & leisure.

Company	Mkt cap	Price	Today
Shionogi & Co., Ltd.SH0.F · agriculture · life sciences · healthcare	13.83B	—	—
Sanofi0O59.IL · travel & leisure · life sciences · healthcare	97.32B	73.78	+0.55%
Bangkok Dusit Medical Services Public Company LimitedBDMS.BK · travel & leisure · life sciences · real estate	305.13B	—	—
China Baoan Group Co., Ltd.000009.SZ · agriculture · travel & leisure · life sciences	16.71B	6.48	−1.37%
Merck & Co., Inc.6MK.F · agriculture · life sciences · healthcare	316.93B	—	—
Menicon Co., Ltd.7780.T · agriculture · life sciences · healthcare	141.53B	—	—
Hyundai Engineering & Construction Co.,Ltd.000720.KS · agriculture · travel & leisure · real estate	10.44T	—	—
Taiba Investment Company4090.SR · agriculture · travel & leisure · real estate	8.30B	16.60	−2.69%

The stocks whose daily moves over the past year went most closely with Mankind Pharma's: the correlation of their daily returns, where 1 would be moving as one.

Company	Mkt cap	Price	Today
Glenmark Pharmaceuticals LimitedGLENMARK.NS · Correlation 0.46	619.23B	2,194.10	−0.73%
Alkem Laboratories LimitedALKEM.NS · Correlation 0.46	599.62B	5,015.00	+0.22%
Zydus Lifesciences LimitedZYDUSLIFE.BO · Correlation 0.45	1.11T	1,117.30	+0.39%
Piramal Pharma LimitedPPLPHARMA.BO · Correlation 0.41	260.76B	—	—
Aurobindo Pharma LimitedAUROPHARMA.NS · Correlation 0.36	908.41B	1,578.80	−2.63%

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All MANKIND.BO news ›

Nation Path India·3d agoPositive

Mankind Pharma Enters Next-Generation Cancer Therapy Market With €48 Million Belgian Biotech Deal

The agreed investment is €48 million, to be paid in instalments in cash. The transaction gives Mankind a majority interest in a biotechnology business developing next-generation chimeric antigen receptor T-cell, or CAR-T, therapies.…

Markets Mojo·3d agoNegative

Mankind Pharma Sees Sharp Open Interest Surge Amid Mixed Market Signals

Such a pronounced rise in open interest alongside substantial volume suggests fresh positions are being established rather than existing ones being squared off. This typically indicates increased conviction among traders, either in…

SME Street·4d agoPositive

Mankind Pharma to Back Next-Generation CAR-T Cancer Therapies

Mankind to invest EUR 48 million for 70% stake in Armed Cell Therapeutics Armed Cell Therapeutics (ACTx) has a pipeline of next-generation CAR-T assets, with lead programs in non-Hodgkin lymphoma and small cell lung cancer ACTx will pursue…

Medical Dialogues·5d ago

Mankind Pharma to Acquire 70% Stake in Armed Cell Therapeutics for Rs 511.4 Crore

Armed Cell Therapeutics is a Belgium-based biotechnology company focused on developing next-generation armed CAR-T therapies for cancer. Its development pipeline includes lead programmes targeting non-Hodgkin lymphoma and small cell lung…

BioSpectrum India·5d agoPositive

Mankind Pharma buys majority stake in Armed Cell Therapeutics for €48 M

BioSpectrum India Mankind Pharma buys majority stake in Armed Cell Therapeutics for â¬48 M October 16, 2026 | Friday | News As a part of its long term strategy to build a global innovation-led pharmaceutical business, Mankind Pharma,…

The Indian Practitioner·5d ago

Mankind Pharma Enters CAR-T Therapy Market with Majority Stake in Armed Cell Therapeutics

Armed Cell Therapeutics was founded by leaders with extensive experience in drug development, cell therapy and biotechnology company building. Dr. Paul Stoffels, Chair of the Board: Former Chief Executive Officer of Galapagos and former…

siliconindia·5d ago

Mankind Pharma to Acquire 70% Stake in ACTx for 48 Million Euros

Siliconindia Mankind Pharma to Acquire 70% Stake in ACTx for 48 Million Euros

Free Press Journal·5d agoPositive

Mankind Pharma To Acquire 70% Stake In Cancer Therapy Firm ACTx, ₹511 Crore Deal Marks Entry Into Advanced Cancer Treatments

Mankind Pharma will acquire 70 percent of Belgium-based ACTx for Rs 511 crore. | Mumbai: Mankind Pharma has announced a major investment in advanced cancer treatment by agreeing to acquire a 70 per cent stake in Belgium-based Armed Cell…

european-biotechnology.com·5d ago

Lakefront offloads CAR-T programs to Armed Cell as Mankind Pharma takes control of the Belgian startup

Lakefront Biotherapeutics, formerly Galapagos, has sold five preclinical CAR-T assets to Belgian startup Armed Cell Therapeutics for €8 million upfront, while India's Mankind Pharma has agreed to acquire 70% of the buyer for €48 million.…

Express Pharma·5d agoPositive

Mankind Pharma to acquire 70% stake in Armed Cell Therapeutics for EUR 48 million

Mankind Pharma, through its subsidiary Mankind Pharma (Netherlands) B.V., has entered into a definitive agreement to acquire a majority stake in Armed Cell Therapeutics B.V. (ACTx), a Belgium-incorporated biotechnology company developing…

From articles in the 4Search news index.

In the news

36mentions in 30 days

36with it in the headline

Positivesentiment

Most coverage from

tradingview.com5
medicaldialogues.in3
scanx.trade3
businessupturn.com2
freepressjournal.in2

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 36 articles, not a forecast.

Key statistics

Against its peers

Related companies

Latest news

In the news

Mentioned with

People in the coverage

Themes

Most coverage from